World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Joe and Jill Biden among several honored at World Stem Cell Summit gala

Joe and Jill Biden among several honored at World Stem Cell Summit gala

by admin | Jan 26, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI – January 25, 2018 –  Greg Simon, president of the Biden Cancer Initiative gives an acceptance speech on behalf of the Bidens. Former Vice President Joe Biden and Dr. Jill...
Interview: Dr. Anthony Atala discusses the future of regenerative medicine

Interview: Dr. Anthony Atala discusses the future of regenerative medicine

by admin | Jan 26, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 – Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine and the W.H. Boyce professor and chair of the Department of Urology at Wake...
Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

by admin | Jan 23, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

MIAMI, Jan. 22, 2018 /PRNewswire/ — Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company’s hometown of Miami for the 2018 World Stem Cell Summit,...
Aging Frailty with Influenza Vaccine Trial announced by Longeveron

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

by admin | Jan 22, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
Longeveron Alzheimer’s Disease Trial

Longeveron Alzheimer’s Disease Trial

by admin | Jan 22, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
Longeveron Aging Frailty Phase 2b Trial

Longeveron Aging Frailty Phase 2b Trial

by admin | Jan 22, 2018 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...
Page 187 of 191« First«...102030...185186187188189...»Last »

Recent Posts

  • CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
  • Stem cell therapy linked to lower risk of heart failure after a heart attack
  • Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
  • Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
  • New UCLA drug could restore heart and organ function
  • Parkinson’s treatment tested at UW showing promise in first clinical trial
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow